587 related articles for article (PubMed ID: 21518602)
1. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
Zhao QM; Feng TT; Zhao X; Xu ZM; Liu Y; Li DP; Li LQ; Su G; Zhang XX
Chin Med J (Engl); 2011 Mar; 124(6):911-7. PubMed ID: 21518602
[TBL] [Abstract][Full Text] [Related]
2. Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques.
Ogawa M; Magata Y; Kato T; Hatano K; Ishino S; Mukai T; Shiomi M; Ito K; Saji H
J Nucl Med; 2006 Nov; 47(11):1845-50. PubMed ID: 17079818
[TBL] [Abstract][Full Text] [Related]
3. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology.
Hyafil F; Cornily JC; Rudd JH; Machac J; Feldman LJ; Fayad ZA
J Nucl Med; 2009 Jun; 50(6):959-65. PubMed ID: 19443582
[TBL] [Abstract][Full Text] [Related]
4. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
Silvola JM; Saraste A; Laitinen I; Savisto N; Laine VJ; Heinonen SE; Ylä-Herttuala S; Saukko P; Nuutila P; Roivainen A; Knuuti J
JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786
[TBL] [Abstract][Full Text] [Related]
5. Comparison of atorvastatin 5 and 20 mg/d for reducing F-18 fluorodeoxyglucose uptake in atherosclerotic plaques on positron emission tomography/computed tomography: a randomized, investigator-blinded, open-label, 6-month study in Japanese adults scheduled for percutaneous coronary intervention.
Ishii H; Nishio M; Takahashi H; Aoyama T; Tanaka M; Toriyama T; Tamaki T; Yoshikawa D; Hayashi M; Amano T; Matsubara T; Murohara T
Clin Ther; 2010 Dec; 32(14):2337-47. PubMed ID: 21353104
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of atherosclerosis evolution by detection of inflammatory states of aortae in a rabbit model using 18F-FDG -PET/CT.
Zhao QM; Zhao X; Feng TT; Zhang MD; Zhuang XC; Zhao XC; Zhang XX; Su G
Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):440-50. PubMed ID: 24518191
[TBL] [Abstract][Full Text] [Related]
7. Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study.
Tawakol A; Fayad ZA; Mogg R; Alon A; Klimas MT; Dansky H; Subramanian SS; Abdelbaky A; Rudd JH; Farkouh ME; Nunes IO; Beals CR; Shankar SS
J Am Coll Cardiol; 2013 Sep; 62(10):909-17. PubMed ID: 23727083
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography.
Tawakol A; Migrino RQ; Hoffmann U; Abbara S; Houser S; Gewirtz H; Muller JE; Brady TJ; Fischman AJ
J Nucl Cardiol; 2005; 12(3):294-301. PubMed ID: 15944534
[TBL] [Abstract][Full Text] [Related]
9. Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection: a pilot study.
Niccoli Asabella A; Ciccone MM; Cortese F; Scicchitano P; Gesualdo M; Zito A; Di Palo A; Angiletta D; Regina G; Marzullo A; Rubini G
Ann Nucl Med; 2014 Jul; 28(6):571-9. PubMed ID: 24737136
[TBL] [Abstract][Full Text] [Related]
10. Detection of vulnerable atherosclerotic plaque and prediction of thrombosis events in a rabbit model using 18F-FDG -PET/CT.
Zhao QM; Zhao X; Feng TT; Zhang MD; Zhuang XC; Zhao XC; Li LQ; Li DP; Liu Y
PLoS One; 2013; 8(4):e61140. PubMed ID: 23613798
[TBL] [Abstract][Full Text] [Related]
11. [Noninvasive imaging of vulnerable plaques and thromboses with PET/CT complex imaging technique].
Zhao X; Zhao QM; Feng TT; Li DP; Liu Y; Li LQ; Zhang MD; Zhuang XC; Zhao XC
Zhonghua Yi Xue Za Zhi; 2013 May; 93(19):1454-7. PubMed ID: 24029566
[TBL] [Abstract][Full Text] [Related]
12. Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [
Hellberg S; Sippola S; Liljenbäck H; Virta J; Silvola JMU; Ståhle M; Savisto N; Metso J; Jauhiainen M; Saukko P; Ylä-Herttuala S; Nuutila P; Knuuti J; Roivainen A; Saraste A
Atherosclerosis; 2017 Aug; 263():369-376. PubMed ID: 28457625
[TBL] [Abstract][Full Text] [Related]
13. FDG-PET can distinguish inflamed from non-inflamed plaque in an animal model of atherosclerosis.
Davies JR; Izquierdo-Garcia D; Rudd JH; Figg N; Richards HK; Bird JL; Aigbirhio FI; Davenport AP; Weissberg PL; Fryer TD; Warburton EA
Int J Cardiovasc Imaging; 2010 Jan; 26(1):41-8. PubMed ID: 19784796
[TBL] [Abstract][Full Text] [Related]
14. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT).
Mehta NN; Torigian DA; Gelfand JM; Saboury B; Alavi A
J Vis Exp; 2012 May; (63):e3777. PubMed ID: 22588186
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography measurement of periodontal 18F-fluorodeoxyglucose uptake is associated with histologically determined carotid plaque inflammation.
Fifer KM; Qadir S; Subramanian S; Vijayakumar J; Figueroa AL; Truong QA; Hoffmann U; Brady TJ; Tawakol A
J Am Coll Cardiol; 2011 Feb; 57(8):971-6. PubMed ID: 21329844
[TBL] [Abstract][Full Text] [Related]
16. Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner.
Millon A; Dickson SD; Klink A; Izquierdo-Garcia D; Bini J; Lancelot E; Ballet S; Robert P; Mateo de Castro J; Corot C; Fayad ZA
Atherosclerosis; 2013 Jun; 228(2):339-45. PubMed ID: 23582588
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography.
Tahara N; Kai H; Ishibashi M; Nakaura H; Kaida H; Baba K; Hayabuchi N; Imaizumi T
J Am Coll Cardiol; 2006 Nov; 48(9):1825-31. PubMed ID: 17084257
[TBL] [Abstract][Full Text] [Related]
18. Relation between thoracic aortic inflammation and features of plaque vulnerability in the coronary tree in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. An FDG-positron emission tomography and optical coherence tomography study.
Taglieri N; Nanni C; Ghetti G; Bonfiglioli R; Saia F; Bacchi Reggiani ML; Lima GM; Marco V; Prati F; Fanti S; Rapezzi C
Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1878-1887. PubMed ID: 28584972
[TBL] [Abstract][Full Text] [Related]
19. Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer ¹⁸F-fluoromethylcholine.
Hellberg S; Silvola JM; Kiugel M; Liljenbäck H; Metsälä O; Viljanen T; Metso J; Jauhiainen M; Saukko P; Nuutila P; Ylä-Herttuala S; Knuuti J; Roivainen A; Saraste A
Cardiovasc Diabetol; 2016 Feb; 15():26. PubMed ID: 26852231
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopathological correlation.
Zhang Z; Machac J; Helft G; Worthley SG; Tang C; Zaman AG; Rodriguez OJ; Buchsbaum MS; Fuster V; Badimon JJ
BMC Nucl Med; 2006 May; 6():3. PubMed ID: 16725052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
